APA (7th ed.) Citation

Sawada, H., Taniguchi, Y., Iizuka, S., Ikeda, T., Aga, M., Hamakawa, Y., . . . Okamoto, H. (2023). Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report. Case Reports in Oncology, 16(1), 1558. https://doi.org/10.1159/000534549

Chicago Style (17th ed.) Citation

Sawada, Hiromune, et al. "Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report." Case Reports in Oncology 16, no. 1 (2023): 1558. https://doi.org/10.1159/000534549.

MLA (9th ed.) Citation

Sawada, Hiromune, et al. "Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report." Case Reports in Oncology, vol. 16, no. 1, 2023, p. 1558, https://doi.org/10.1159/000534549.